Sjogren-Larsson syndrome (SLS) is a rare neurocutaneous disorder caused by an inborn error of lipid metabolism. While it has a global prevalence of 1:250,000, it is found to be more common in Sweden owing to a founder effect. The condition is characterised by congenital ichthyosis, intellectual deficit, diplegia or tetraplegia, and spasticity.